When finalized, the guideline will provide countries with recommendations on limiting the consumption of sugars to reduce public health problems like obesity and dental caries commonly referred to as tooth decay. Comments on the draft guideline will be accepted via the WHO web site from 5 through 31 March Anyone who wishes to comment must submit a declaration of interests.
PY - Y1 - N2 - Hypertension is the most common condition seen in primary care and leads to myocardial infarction, stroke, renal failure, and death if not detected early and treated appropriately.
Patients want to be assured that blood pressure BP treatment will reduce their disease burden, while clinicians want guidance on hypertension management using the best scientific evidence. This report takes a rigorous, evidence-based approach to recommend treatment thresholds, goals, and medications in the management of hypertension in adults.
Evidence was drawn from randomized controlled trials, which represent the gold standard for determining efficacy and effectiveness.
Evidence quality and recommendations were graded based on their effect on important outcomes. The same thresholds and goals are recommended for hypertensive adults with diabetes or nondiabetic chronic kidney disease CKD as for the general hypertensive population younger than 60 years.
There is moderate evidence to support initiating drug treatment with an angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, calcium channel blocker, or thiazide-type diuretic in the nonblack hypertensive population, including those with diabetes.
In the black hypertensive population, including those with diabetes, a calcium channel blocker or thiazide-type diuretic is recommended as initial therapy. There is moderate evidence to support initial or add-on antihypertensive therapy with an angiotensin- converting enzyme inhibitor or angiotensin receptor blocker in persons with CKD to improve kidney outcomes.
Although this guideline provides evidence-based recommendations for the management of high BP and should meet the clinical needs of most patients, these recommendations are not a substitute for clinical judgment, and decisions about care must carefully consider and incorporate the clinical characteristics and circumstances of each individual patient.
AB - Hypertension is the most common condition seen in primary care and leads to myocardial infarction, stroke, renal failure, and death if not detected early and treated appropriately.1.
INTRODUCTION Aim and objectives. The European Association of Urology (EAU) Guidelines on Penile Cancer provides up-to-date information on the diagnosis and management of penile squamous cell carcinoma (SCC).
5 March | GENEVA - WHO is launching a public consultation on its draft guideline on sugars intake. When finalized, the guideline will provide countries with recommendations on limiting the consumption of sugars to reduce public health problems like obesity and dental caries (commonly referred to as tooth decay).
Bacteria and fungi occur as individual, free-floating (planktonic) cells or clustered together in aggregates of cells (biofilms). A microbial biofilm is ‘a structured consortium of microbial cells surrounded by a self-produced polymer matrix’ In addition to microorganisms, components from the host, such as fibrin, platelets or immunoglobulins, may be integrated into the biofilm matrix.
Guidelines for Management of High Blood Pressure in Adults. In , panel members of the Eighth Joint National Committee published the results of their evidence review and deliberations about the prevention, detection, evaluation, and treatment of high blood pressure.
ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, ACCF/AHA Guideline for Coronary Artery Bypass Graft .
A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.